{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:12Z","timestamp":1787020812709,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF20OC0064043"],"award-info":[{"award-number":["NNF20OC0064043"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0028706"],"award-info":[{"award-number":["NNF17OC0028706"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0055142"],"award-info":[{"award-number":["NNF19OC0055142"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R186-2015-2132"],"award-info":[{"award-number":["R186-2015-2132"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) involving systemic inflammation. The severity of the inflammatory response is associated with adverse outcome, with anoxic irreversible brain injury as the leading cause of death following resuscitated OHCA. The study aimed to investigate the anti-inflammatory and neuroprotective effect of pre-hospital administration of a high-dose glucocorticoid following OHCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study is an investigator-initiated, randomized, multicenter, single-blinded, placebo-controlled, clinical trial. Inclusion will continue until one hundred twenty unconscious OHCA patients surviving a minimum of 72\u00a0h are randomized. Intervention is a 1:1 randomization to an infusion of methylprednisolone 250\u00a0mg following a minimum of 5\u00a0min of sustained return of spontaneous circulation in the pre-hospital setting. Methylprednisolone will be given as a bolus infusion of 1\u2009\u00d7\u2009250\u00a0mg (1\u2009\u00d7\u20094\u00a0mL) over a period of 5\u00a0min. Patients allocated to placebo will receive 4\u00a0mL of isotonic saline (NaCl 0.9%). Main eligibility criteria are OHCA of presumed cardiac cause, age\u2009\u2265\u200918\u00a0years, Glasgow Coma Scale\u2009\u2264\u20098, and sustained ROSC for at least 5\u00a0min. Co-primary endpoint: Reduction of interleukin-6 and neuron-specific-enolase. Secondary endpoints: Markers of inflammation, brain, cardiac, kidney and liver damage, hemodynamic and hemostatic function, safety, neurological function at follow-up, and mortality. A research biobank is set up with blood samples taken daily during the first 72\u00a0h from hospitalization to evaluate primary and secondary endpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We hypothesize that early anti-inflammatory steroid treatment in the pre-hospital setting can mitigate the progression of PCAS following resuscitated OHCA. Primary endpoints will be assessed through analyses of biomarkers for inflammation and neurological damage taken during the first 72\u00a0h of admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      EudraCT number:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-000855-11\/DK\/\">2020-000855-11<\/jats:ext-link>\n                      ; submitted March 30, 2020\n                    <\/jats:p>\n                    <jats:p>ClinicalTrials.gov Identifier: NCT04624776; submitted October 12, 2020, first posted November 10, 2020<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06838-0","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T20:27:19Z","timestamp":1669148839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-3670","authenticated-orcid":false,"given":"Laust Emil Roelsgaard","family":"Obling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Paulin","family":"Beske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Folke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Eifer","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kjaergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hassager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"6838_CR1","unstructured":"Lippert FK, Christensen EF, Hansen PA, Torp-Pedersen C. Danish Cardiac Arrest Register - Annual Report.; 2020. https:\/\/hjertestopregister.dk\/?page_id=428. Accessed 05 Apr 2022."},{"issue":"1","key":"6838_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/CIRCOUTCOMES.109.889576","volume":"3","author":"C Sasson","year":"2010","unstructured":"Sasson C, Rogers MAM, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2010;3(1):63\u201381.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"6838_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.resuscitation.2012.06.029","volume":"84","author":"H S\u00f8holm","year":"2013","unstructured":"S\u00f8holm H, Wachtell K, Nielsen SL, Bro-Jeppesen J, Pedersen F, Wanscher M, Boesgaard S, M\u00f8ller JE, Hassager C, Kjaergaard J. Tertiary centres have improved survival compared to other hospitals in the Copenhagen area after out-of-hospital cardiac arrest. Resuscitation. 2013;84(2):162\u20137.","journal-title":"Resuscitation"},{"key":"6838_CR4","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.108.190652","volume":"118","author":"RW Neumar","year":"2008","unstructured":"Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, B\u00f6ttiger BW, Callaway C, Clark RSB, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT, Merchant RM, Morley P, et al. Post\u2013cardiac arrest syndrome epidemiology, pathophysiology, treatment, and prognostication a consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Stroke Foundation of Canada,. Circulation. 2008;118:2452\u201383.","journal-title":"Circulation"},{"issue":"13","key":"6838_CR5","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.110.988725","volume":"123","author":"D Stub","year":"2011","unstructured":"Stub D, Bernard S, Duffy SJ, Kaye DM. Post cardiac arrest syndrome: a review of therapeutic strategies. Circulation. 2011;123(13):1428\u201335.","journal-title":"Circulation"},{"issue":"18","key":"6838_CR6","first-page":"S465","volume":"132","author":"CW Callaway","year":"2015","unstructured":"Callaway CW, Donnino MW, Fink EL, Geocadin RG, Golan E, Kern KB, Leary M, Meurer WJ, Peberdy MA, Thompson TM, Zimmerman JL. Part 8: Post-cardiac arrest care: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18):S465\u201382.","journal-title":"Circulation"},{"key":"6838_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.resuscitation.2016.01.006","volume":"103","author":"MA Peberdy","year":"2016","unstructured":"Peberdy MA, Andersen LW, Abbate A, Thacker LR, Gaieski D, Abella BS, Grossestreuer AV, Rittenberger JC, Clore J, Ornato J, Cocchi MN, Callaway C. Inflammatory markers following resuscitation from out-of-hospital cardiac arrest: a prospective multicenter observational study. Resuscitation. 2016;103:117\u201324.","journal-title":"Resuscitation"},{"issue":"11","key":"6838_CR8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.resuscitation.2014.08.036","volume":"85","author":"J Vaahersalo","year":"2014","unstructured":"Vaahersalo J, Skrifvars MB, Pulkki K, Stridsberg M, R\u00f8sj\u00f8 H. Admission interleukin-6 is associated with post resuscitation organ dysfunction and predicts long-term neurological outcome after out-of-hospital ventricular fibrillation. Resuscitation. 2014;85(11):1573\u20139.","journal-title":"Resuscitation"},{"key":"6838_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.resuscitation.2015.10.009","volume":"98","author":"J Bro-Jeppesen","year":"2016","unstructured":"Bro-Jeppesen J, Kjaergaard J, Stammet P, Wise MP, Hovdenes J, \u00c5neman A, Horn J, Devaux Y, Erlinge D, Gasche Y, Wanscher M, Cronberg T, Friberg H, Wetterslev J, Pellis T, et al. Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33\u00b0C or 36\u00b0C. Resuscitation. 2016;98:1\u20138.","journal-title":"Resuscitation"},{"key":"6838_CR10","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1007\/s00134-004-2425-z","volume":"30","author":"S Laver","year":"2004","unstructured":"Laver S. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004;30:2126\u20138.","journal-title":"Intensive Care Med"},{"issue":"3","key":"6838_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.resuscitation.2012.09.015","volume":"84","author":"I Dragancea","year":"2013","unstructured":"Dragancea I, Rundgren M, Englund E, Friberg H, Cronberg T. The influence of induced hypothermia and delayed prognostication on the mode of death after cardiac arrest. Resuscitation. 2013;84(3):337\u201342.","journal-title":"Resuscitation"},{"issue":"3","key":"6838_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1213\/ane.0b013e318193ca99","volume":"108","author":"A Schneider","year":"2009","unstructured":"Schneider A, B\u00f6ttiger BW, Popp E. Cerebral resuscitation after cardiocirculatory arrest. Anesth Analg. 2009;108(3):971\u20139.","journal-title":"Anesth Analg"},{"issue":"6","key":"6838_CR13","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/CCM.0000000000000937","volume":"43","author":"J Bro-Jeppesen","year":"2015","unstructured":"Bro-Jeppesen J, Kjaergaard J, Wanscher M, Nielsen N, Friberg H, Bjerre M, Hassager C. Systemic inflammatory response and potential prognostic implications after out-of-hospital cardiac arrest: a substudy of the target temperature management trial. Crit Care Med. 2015;43(6):1223\u201332.","journal-title":"Crit Care Med"},{"key":"6838_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0300-9572(03)00164-3","volume":"59","author":"M Fries","year":"2003","unstructured":"Fries M, Kunz D, Gressner AM, Rossaint R, Kuhlen R. Procalcitonin serum le v els after out-of-hospital cardiac arrest. Resuscitation. 2003;59:105\u20139.","journal-title":"Resuscitation"},{"issue":"19","key":"6838_CR15","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.jacc.2015.03.538","volume":"65","author":"P Stammet","year":"2015","unstructured":"Stammet P, Collignon O, Hassager C, Wise MP, Hovdenes J, \u00c5neman A, Horn J, Devaux Y. Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33C and 36C. J Am Coll Cardiol. 2015;65(19):2104\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"6838_CR16","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1161\/CIRCULATIONAHA.116.024088","volume":"134","author":"S Wiberg","year":"2016","unstructured":"Wiberg S, Hassager C, Schmidt H, Thomsen JH, Frydland M, Lindholm MG, H\u00f8fsten DE, Engstr\u00f8m T, K\u00f8ber L, M\u00f8ller JE, Kjaergaard J. Neuroprotective effects of the glucagon-like peptide-1 analog exenatide after out-of-hospital cardiac arrest: a randomized controlled trial. Circulation. 2016;134(25):2115\u201324.","journal-title":"Circulation"},{"issue":"9","key":"6838_CR17","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1097\/00003246-199309000-00018","volume":"21","author":"CH Schultz","year":"1993","unstructured":"Schultz CH, Rivers EP, Feldkamp CS, Goad EG, Smithline HA, Martin GB, Fath JJ, Wortsman J, Nowak RM. A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit Care Med. 1993;21(9):1339\u201347.","journal-title":"Crit Care Med"},{"issue":"2","key":"6838_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/01.shk.0000132489.79498.c7","volume":"22","author":"G H\u00e9kimian","year":"2004","unstructured":"H\u00e9kimian G, Baugnon T, Thuong M, Monchi M, Dabbane H, Jaby D, Rhaoui A, Laurent I, Moret G, Fraisse F, Adrie C. Cortisol levels and adrenal reserve after successful cardiac arrest resuscitation. Shock. 2004;22(2):116\u20139.","journal-title":"Shock"},{"key":"6838_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/cs0940557","volume":"94","author":"PJ Barnes","year":"1998","unstructured":"Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci. 1998;94:557\u201372.","journal-title":"Clin Sci"},{"issue":"3","key":"6838_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.iac.2005.05.003","volume":"25","author":"PJ Barnes","year":"2005","unstructured":"Barnes PJ. Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin North Am. 2005;25(3):451\u201368.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"6838_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/ecp.11.1","volume":"4","author":"J Dietrich","year":"2011","unstructured":"Dietrich J, Rao K, Pastorino S, Kesari S. Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol. 2011;4(2):233\u201342.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6838_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10557-014-6547-4","volume":"28","author":"G Varvarousi","year":"2014","unstructured":"Varvarousi G, Stefaniotou A. Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation. Cardiovascular Drugs Therapy. 2014;28:477\u201388.","journal-title":"Cardiovascular Drugs Therapy"},{"issue":"10","key":"6838_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ncprheum0898","volume":"4","author":"C Stahn","year":"2008","unstructured":"Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008;4(10):525\u201333.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"6838_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/archinternmed.2008.509","volume":"169","author":"SD Mentzelopoulos","year":"2009","unstructured":"Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, Katsios N, Papastylianou A, Gkisioti S, Stathopoulos A, Kollintza A, Stamataki E, Roussos C. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med. 2009;169(1):15\u201324.","journal-title":"Arch Intern Med"},{"issue":"3","key":"6838_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1001\/jama.2013.7832","volume":"310","author":"SD Mentzelopoulos","year":"2013","unstructured":"Mentzelopoulos SD, Malachias S, Chamos C, Konstantopoulos D, Ntaidou T, Papastylianou A, Kolliantzaki I, Theodoridi M, Ischaki H, Makris D, Zakynthinos E, Zintzaras E, Sourlas S, Aloizos S, Zakynthinos SG. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2013;310(3):270\u20139.","journal-title":"JAMA"},{"issue":"16","key":"6838_CR26","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1001\/jama.2021.16628","volume":"326","author":"LW Andersen","year":"2021","unstructured":"Andersen LW, Isbye D, Kj\u00e6rgaard J, Kristensen CM, Darling S, Zwisler ST, Fisker S, Schmidt JC, Kirkegaard H, Grejs AM, Rossau JRG, Larsen JM, Rasmussen BS, Riddersholm S, Iversen K, et al. Effect of vasopressin and methylprednisolone vs placebo on return of spontaneous circulation in patients with in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2021;326(16):1586\u201394.","journal-title":"JAMA"},{"issue":"1","key":"6838_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.01.062","volume":"76","author":"A Caplan","year":"2017","unstructured":"Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: a comprehensive review: a review of glucocorticoid pharmacology and bone health. J Am Acad Dermatol. 2017;76(1):1\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"6838_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMoa052620","volume":"355","author":"LJ Morrison","year":"2006","unstructured":"Morrison LJ, Visentin LM, Kiss A, Theriault R, Eby D, Vermeulen M, Sherbino J, Verbeek PR. Validation of a rule for termination of resuscitation in out-of-hospital cardiac arrest. N Engl J Med. 2006;355(5):478\u201387.","journal-title":"N Engl J Med"},{"issue":"2","key":"6838_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.resuscitation.2007.01.009","volume":"74","author":"LJ Morrison","year":"2007","unstructured":"Morrison LJ, Verbeek PR, Vermeulen MJ, Kiss A, Allan KS, Nesbitt L, Stiell I. Derivation and evaluation of a termination of resuscitation clinical prediction rule for advanced life support providers. Resuscitation. 2007;74(2):266\u201375.","journal-title":"Resuscitation"},{"issue":"10","key":"6838_CR30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s12098-008-0210-7","volume":"75","author":"A Sinha","year":"2008","unstructured":"Sinha A, Bagga A. Pulse steroid therapy. Indian J Pediatr. 2008;75(10):1057\u201366.","journal-title":"Indian J Pediatr"},{"key":"6838_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.resuscitation.2016.01.006","volume":"103","author":"MA Peberdy","year":"2016","unstructured":"Peberdy MA, Andersen LW, Abbate A, Thacker LR, Gaieski D, Abella BS, Grossestreuer AV, Rittenberger JC, Clore J, Ornato J, Cocchi MN, Callaway C, Donnino M, Roberts CS, Gossip M, et al. Inflammatory markers following resuscitation from out-of-hospital cardiac arrest-a prospective multicenter observational study. Resuscitation. 2016;103:117\u201324.","journal-title":"Resuscitation"},{"issue":"October 2020","key":"6838_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.resuscitation.2020.11.016","volume":"158","author":"M H\u00f8ybye","year":"2021","unstructured":"H\u00f8ybye M, Stankovic N, Holmberg M, Christensen HC, Granfeldt A, Andersen LW. In-hospital vs out-of-hospital cardiac arrest: patient characteristics and survival. Resuscitation. 2021;158(October 2020):157\u201365.","journal-title":"Resuscitation"},{"key":"6838_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.resuscitation.2021.02.012","volume":"161","author":"JP Nolan","year":"2021","unstructured":"Nolan JP, Sandroni C, B\u00f6ttiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VRM, Nikolaou N, Mariero Olasveengen T, Skrifvars MB, Taccone F, Soar J. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: post-resuscitation care. Resuscitation. 2021;161:220\u201369.","journal-title":"Resuscitation"},{"key":"6838_CR34","doi-asserted-by":"crossref","unstructured":"Wyckoff MH, Singletary EM, Soar J, Olasveengen TM, Greif R, Liley HG, Zideman D, Bhanji F, Andersen LW, Avis SR, Aziz K, Bendall JC, Berry DC, Borra V, B\u00f6ttiger BW, et al. 2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and Teams.; 2022.","DOI":"10.1542\/peds.2022-060463"},{"issue":"16","key":"6838_CR35","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids \u2014 new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711\u201323.","journal-title":"N Engl J Med"},{"issue":"1","key":"6838_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","volume":"40","author":"RA Panettieri","year":"2019","unstructured":"Panettieri RA, Schaafsma D, Amrani Y, Koziol-White C, Ostrom R, Tliba O. Non-genomic effects of glucocorticoids: an updated view. Trends Pharmacol Sci. 2019;40(1):38\u201349.","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"6838_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00424-012-1155-2","volume":"464","author":"SR Lee","year":"2012","unstructured":"Lee SR, Kim HK, Youm JB, Dizon LA, Song IS, Jeong SH, Seo DY, Ko KS, Rhee BD, Kim N, Han J. Non-genomic effect of glucocorticoids on cardiovascular system. Pfl\u00fcgers Archiv. 2012;464(6):549\u201359.","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"10","key":"6838_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells8101227","volume":"8","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang TN, Knight JK, Goodwin JE. The glucocorticoid receptor in cardiovascular health and disease. Cells. 2019;8(10):1\u201321.","journal-title":"Cells"},{"issue":"2","key":"6838_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.18700\/jnc.170035","volume":"10","author":"S Samuel","year":"2017","unstructured":"Samuel S, Nguyen T, Choi HA. Pharmacologic characteristics of corticosteroids. J Neurocrit Care. 2017;10(2):53\u20139.","journal-title":"J Neurocrit Care"},{"issue":"1","key":"6838_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2826.2011.02161.x","volume":"24","author":"N Schweingruber","year":"2012","unstructured":"Schweingruber N, Reichardt SD, L\u00fchder F, Reichardt HM. Mechanisms of glucocorticoids in the control of neuroinflammation. J Neuroendocrinol. 2012;24(1):174\u201382.","journal-title":"J Neuroendocrinol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06838-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06838-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06838-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T20:28:53Z","timestamp":1669148933000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06838-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6838"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06838-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior to initiation of the trial, permissions were obtained from the Regional Ethics Committee (ID: H-20022320) and the Danish Medicines Agency (ID: 2020033425), and a legal data handling agreement was approved by the Capital Region of Denmark (ID: P-2020\u2013866). Further, a monitoring agreement of adherence to national and international guidelines was made with the GCP-unit of Copenhagen prior to initiation.This trial sought to inhibit the inflammatory state developing in OHCA patients following resuscitation, and injection of study medicine is therefore initiated as soon as possible in the pre-hospital setting. Similar studies and knowledge cannot be obtained in another setting, i.e., in non-comatose patients, and the risks associated to the intervention are considered acceptable. Based on the acute nature of the trial, informed consent of inclusion will be obtained from the primary trial guardian (on-duty physician at the coordinating center of the EMS Copenhagen) which later will be confirmed by the secondary trial guardian (physician at the Department of Thoracic Anesthesiology, Rigshospitalet). Informed consent from the nearest relatives will be obtained as soon as possible following admission to the hospital and further from the patient upon regained consciousness. The process of obtaining consent will be according to national legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"Consent forms for the trial guardians, patient relatives and the patient are all available upon request. All consent forms have been approved by relevant authorities and are written in Danish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"952"}}